Decoy Therapeutics is trading at $4.44 (+10.17%) as it extends a rebound triggered by July 28 lab results for its Ebola Zaire platform.
- The move appears to be continuation buying following a 5.7% gain in after-hours trading on July 29, with no new specific catalysts reported today.
- Broader market strength is providing additional tailwinds, with the Nasdaq climbing more than 2%.